Skip to main content
Fig. 7 | BMC Complementary Medicine and Therapies

Fig. 7

From: Network Pharmacology Approach to Uncover the Mechanism Governing the Effect of Radix Achyranthis Bidentatae on Osteoarthritis

Fig. 7

Molecular docking of compounds with core targets. (a1) Docking process of quercetin with IL6; (a2) Docking process of celecoxib with IL6; (b1) Docking process of quercetin with VEGFA; (b2) Docking process of celecoxib with VEGFA; (c1) Docking process of quercetin with CCND1; (c2) Docking process of celecoxib with CCND1; (d1) Docking process of quercetin with MAPK8; (d2) Docking process of celecoxib with MAPK8; (e1) Docking process of quercetin with CASP3; (e2) Docking process of celecoxib with CASP3; (f1) Docking process of quercetin with EGFR; (f2) Docking process of celecoxib with EGFR; (g1) Docking process of quercetin with MYC; (g2) Docking process of celecoxib with MYC

Back to article page